445.70
+9.66
+(2.22%)
At close: 5:59:24 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 11 | 11 | 14 | 13 |
Avg. Estimate | 46.26B | 47.73B | 191.66B | 205.51B |
Low Estimate | 45.39B | 47.36B | 184.96B | 198.94B |
High Estimate | 48.23B | 48.31B | 194.25B | 210.05B |
Year Ago Sales | 42.27B | 43.22B | 175.2B | 191.66B |
Sales Growth (year/est) | 9.44% | 10.43% | 9.39% | 7.23% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
0HG8.L | -- | -- | -- | -- |
S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
Reiterates | Argus Research: Hold to Hold | 1/29/2025 |
Maintains | Wells Fargo: Overweight to Overweight | 1/28/2025 |
Reiterates | Cantor Fitzgerald: Overweight to Overweight | 1/24/2025 |
Maintains | Barclays: Overweight to Overweight | 1/24/2025 |
Maintains | Truist Securities: Buy to Buy | 1/6/2025 |
Maintains | Mizuho: Outperform to Outperform | 11/5/2024 |